Human medicines European public assessment report (EPAR): Revlimid, lenalidomide, Multiple Myeloma;Lymphoma, Mantle-Cell;Myelodysplastic Syndromes, Date of authorisation: 14/06/2007, Revision: 51, Status: Authorised

Human medicines European public assessment report (EPAR): Revlimid, lenalidomide, Multiple Myeloma;Lymphoma, Mantle-Cell;Myelodysplastic Syndromes, Date of authorisation: 14/06/2007, Revision: 51, Status: Authorised

Focus group on veterinary pharmacovigilance reporting in aquaculture, European Medicines Agency, 10:00 - 17:00 Amsterdam time (CEST), from 22/11/2023 to 22/11/2023

Focus group on veterinary pharmacovigilance reporting in aquaculture, European Medicines Agency, 10:00 - 17:00 Amsterdam time (CEST), from 22/11/2023 to 22/11/2023

Focus group meeting for veterinarians or other healthcare professionals on facilitating pharmacovigilance reporting of medicinal products used in aquaculture, European Medicines Agency, 10:00 - 17:00 Amsterdam time (CEST), from 22/11/2023 to 22/11/2023

Focus group meeting for veterinarians or other healthcare professionals on facilitating pharmacovigilance reporting of medicinal products used in aquaculture, European Medicines Agency, 10:00 - 17:00 Amsterdam time (CEST), from 22/11/2023 to 22/11/2023

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.